Gershengorn M C, Thaw C
Endocrinology. 1985 Feb;116(2):591-6. doi: 10.1210/endo-116-2-591.
TRH stimulation appears to be coupled to PRL secretion, at least in part, by elevation of the concentration of Ca2+ free in the cytoplasm [( Ca2+]i). We employed an intracellularly trapped fluorescent probe of Ca2+, Quin 2, to measure [Ca2+]i in GH3 cells, cloned rat pituitary tumor cells. Basal [Ca2+]i in GH3 cells incubated in medium containing 1.5 mM Ca2+ was 148 +/- 8.6 nM (mean +/- SE). TRH caused a biphasic elevation of [Ca2+]i to 517 +/- 29 nM at less than 10 sec after TRH addition, followed by a decline towards the resting level over 1.5 min (first phase) and then a sustained elevation to 261 +/- 14 nM (second phase). We attempted to determine whether mobilization of cellular calcium or enhanced influx of extracellular Ca2+, or both, were involved in the elevation of [Ca2+]i during each of the two phases. In all experiments, the elevation of [Ca2+]i stimulated by TRH was compared with that induced by depolarization of the plasma membrane with high extracellular K+, which enhances Ca2+ influx. In medium with 1.5 mM Ca2+, K+-depolarization caused an elevation of [Ca2+]i to 780 +/- 12 nM. When the concentration of Ca2+ in the medium was lowered to 0.1 mM and 0.01 mM, basal [Ca2+]i was lowered to 114 +/- 3.4 and 110 +/- 11 nM, respectively. In medium with 0.1 and 0.01 mM Ca2+, peak K+ depolarization-induced elevation of [Ca2+]i was lowered to 30 +/- 3.9% and 7.3 +/- 2.0% of control, respectively. The peak second phase increase caused by TRH was reduced to 33 +/- 2.8% and 16 +/- 5.6% of control, respectively, whereas the peak first phase elevation of [Ca2+]i was lowered only to 79 +/- 5.5% and 52 +/- 10% of control in medium with 0.1 mM and 0.01 mM Ca2+, respectively. When cells were incubated in medium with 1.5 mM Ca2+ containing the Ca2+-channel blocking agents, nifedipine and verapamil, basal [Ca2+]i was not affected. Nifedipine plus verapamil, each at a maximally effective dose, lowered K+ depolarization-induced elevation of [Ca2+]i to 6.5 +/- 1.0% of control, the peak second phase increase caused by TRH to 28 +/- 4.3% of control, but the peak first phase elevation only to 64 +/- 3.7% of control. The decrease in the first phase response to TRH caused by the channel blockers appeared to be secondary to partial depletion of an intracellular, nonmitochondrial calcium pool.(ABSTRACT TRUNCATED AT 400 WORDS)
促甲状腺激素释放激素(TRH)刺激似乎至少部分地通过提高细胞质中游离钙离子([Ca2+]i)的浓度与催乳素分泌相偶联。我们使用一种细胞内捕获的钙离子荧光探针喹啉2(Quin 2)来测量生长激素3(GH3)细胞(克隆的大鼠垂体瘤细胞)中的[Ca2+]i。在含有1.5 mM钙离子的培养基中培养的GH3细胞,其基础[Ca2+]i为148±8.6 nM(平均值±标准误)。添加TRH后不到10秒,TRH使[Ca2+]i双相升高至517±29 nM,随后在1.5分钟内降至静息水平(第一阶段),然后持续升高至261±14 nM(第二阶段)。我们试图确定在两个阶段中,细胞内钙离子的动员或细胞外钙离子流入的增强,或两者是否都参与了[Ca2+]i的升高。在所有实验中,将TRH刺激引起的[Ca2+]i升高与用高细胞外钾使质膜去极化诱导的[Ca2+]i升高进行比较,后者可增强钙离子流入。在含有1.5 mM钙离子的培养基中,钾去极化使[Ca2+]i升高至780±12 nM。当培养基中钙离子浓度降至0.1 mM和0.01 mM时,基础[Ca2+]i分别降至114±3.4和110±11 nM。在含有0.1 mM和0.01 mM钙离子的培养基中,钾去极化诱导的[Ca2+]i峰值升高分别降至对照的30±3.9%和7.3±2.0%。TRH引起的第二阶段峰值升高分别降至对照的33±2.8%和16±5.6%,而在含有0.1 mM和0.01 mM钙离子的培养基中,第一阶段[Ca2+]i峰值升高分别仅降至对照的79±5.5%和52±10%。当细胞在含有1.5 mM钙离子并添加钙离子通道阻滞剂硝苯地平和维拉帕米的培养基中培养时,基础[Ca2+]i不受影响。硝苯地平和维拉帕米各以最大有效剂量联合使用时,钾去极化诱导的[Ca2+]i升高降至对照的6.5±1.0%,TRH引起的第二阶段峰值升高降至对照的28±4.3%,但第一阶段峰值升高仅降至对照的64±3.7%。通道阻滞剂引起的对TRH第一阶段反应的降低似乎继发于细胞内非线粒体钙库的部分耗竭。(摘要截断于400字)